From uniform treatments to personalised cancer care In Ireland, the cancer treatment landscape has shifted dramatically over the last decade. Patients who once faced a one-size-fits-all approach now benefit from personalised strategies that target the biology of their disease. For Lydia Whelan, a 32-year-old diagnosed with stage 2 HER2+ breast cancer in 2024, this evolution…